Jaguar Animal Health

Voir l'organigramme avec ses 16 principaux dirigeants

Biographies les plus recherchées chez Jaguar Animal Health

• Lisa Conte, Chief Executive Officer, Executive Director
• John Micek, Director
• James Bochnowski, Chairman of the Board

Changements de dirigeants chez Jaguar Animal Health

• Massimo Radaelli, a rejoint l'entreprise comme President of International  (publié le 3 avril 2024).

Créer une alerte
pour suivre les mouvements de dirigeants chez Jaguar Animal Health.

Jaguar Animal Health a 1 867 concurrents dont Pfizer (Etats—Unis), Sanofi (France) et Johnson & Johnson (Etats—Unis).

Actualités en fusion/acquisition en Pharmacie.

• AstraZeneca has announced the acquisition of Fusion Pharma  (publié le 23 mars 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (publié le 19 mars 2024).
• Frontier Medicines vient d'annoncer une levée de fonds de 80 millions de dollars. (publié le 27 février 2024).

Contacts en Pharmacie

• Jean-Frédéric Paulsen - Executive Chairman of the Board chez Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director chez Dirk Rossmann
• Thierry Abribat - Chief Executive Officer chez Amolyt Pharma

En savoir plus sur le secteur Pharmacie >

Derniers communiqués de presse par Jaguar Animal Health

• Jaguar Health Appoints Senior Healthcare and Investment Executive Dr. Anula Jayasuriya to Board of Directors and Forms Business Development Advisory Committee to Assess Opportunities for Alliances, Mergers, and Acquisitions | Jaguar Health, Inc.
• Jaguar Health Enters Exclusive Crofelemer License and Commercialization Agreement with SynWorld Technologies for Canalevia for Treatment of Diarrhea in Dogs in China | Jaguar Health, Inc.
• Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Jaguar Health, Inc.
• Jaguar Health Announces Online Availability of a Presentation on Short Bowel Syndrome (SBS) by Dr. Mohamad Miqdady at Elite Ped-GI Congress in Abu Dhabi | Jaguar Health, Inc.
• Jaguar Animal Health Exhibiting at the June 23-25 American College of Veterinary Internal Medicine (ACVIM) Forum as Part of Ongoing Commercial Launch Activities for Canalevia-CA1 | Jaguar Health, Inc.
• Jaguar Health Announces Publication of Onco'Zine Article Underscoring the Importance of Controlling Diarrhea in Cancer Patients | Jaguar Health, Inc.
• Jaguar Health Reports Voting Results from 2022 Annual Meeting of Stockholders | Jaguar Health, Inc.
• Jaguar Health to Participate in BIO International Convention (BIO 2022) | Jaguar Health, Inc.
• Jaguar Health and Filament Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications | Jaguar Health, Inc.
• Jaguar Health Announces Napo Therapeutics' Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition | Jaguar Health, Inc.
• Voir plus de communiqués de presse Close

Réseaux sociaux à propos de Jaguar Animal Health

• Jaguar Animal Health sur Wikipédia, Google News & Yahoo Finance en 1-click
• Jaguar Animal Health sur LinkedIn, Twitter & YouTube en 1-click

Contacter par email ses dirigeants dont Lisa Conte

Appelez Jaguar Animal Health au +1 415...

Voir l'organigramme

S'inscrire pour recevoir votre alerte

Signaler une erreur